T1	Participants 14 111	therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome.
T2	Participants 285 360	Overall, 64 adult patients with GBS for PE and IVIg treatment, respectively
T3	Participants 147 274	the clinical curative effect of the plasma exchange (PE) and intravenous immunoglobulin (IVIg) for Guillian-Barre Syndrome (GBS
